Age and persistence of chronic endometritis on repeat biopsy: a 25-year territory-wide cohort study

Chronic endometritis (CE) is a persistent inflammatory disorder of the endometrium that has been associated with impaired endometrial receptivity and implantation failure. The role of antibiotic therapy has been debated with treatment responses variable. This study aimed to identify factors associated with persistence of CE at follow-up biopsy in a large real-world cohort. Clinical data of patients diagnosed with CE were extracted from the Clinical Data Analysis and Reporting System (CDARS) of the Hong Kong Hospital Authority between January 2000 and December 2024. Patients with histopathologically confirmed CE with follow-up endometrial biopsy were included. Consecutive pathology records within 14 days were collapsed into a single episode; the first and second episodes were designated TP1 and TP2, and only patients with a TP2 episode at least 14 days after TP1 were analyzed. The primary outcome was persistence of CE at TP2. Of 14,988 patients with pathologically confirmed CE, 3,119 had matched follow-up. The overall resolution rate was 79.8% (2,490/3,119). Univariable analysis showed higher odds of persistence with penicillin/beta-lactamase inhibitor (OR 1.41, 95% CI 1.06–1.86, p = 0.016), narrow-spectrum penicillins (OR 1.88, 95% CI 1.09–3.13, p = 0.019) and fluoroquinolones (OR 2.48, 95% CI 1.20–4.92, p = 0.011). After multivariable adjustment, no antibiotic class was significantly associated with treatment outcome. Age was the only factor independently associated with persistence. Compared with the reference group (25–44 years), patients aged 45–59 years had significantly lower odds of persistence (aOR 0.77; 95% CI 0.64–0.93; p = 0.007), whereas those aged ≥ 75 years had higher odds (aOR 2.29; 95% CI, 1.52–3.43; p < 0.001). The ≤ 24-year and 60–74-year groups did not differ significantly from the reference (aOR 0.94, 95% CI 0.14–3.80 and aOR 1.06, 95% CI 0.57–1.86, respectively). Baseline and change in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), or systemic immune-inflammation index (SII) were insignificant (p>0.05). Persistence of CE was associated with age in a non-linear pattern, with lower odds in women aged 45–59 years and higher odds in those aged ≥ 75 years relative to the 25–44-year reference. Antibiotic class is not associated with treatment outcomes, and blood-based inflammatory markers were not associated with treatment response; current data provide insufficient evidence to support their use for routine treatment monitoring. Due to poor model discrimination, age identifies a population at higher risk rather than a usable individual predictor. These findings support further study of age-related persistence but do not support age-based treatment decisions.

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2026-11-18
DOI
https://doi.org/10.1186/s12905-026-05143-1
Primary Topic
Gynecological conditions and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Age and persistence of chronic endometritis on repeat biopsy: a 25-year territory-wide cohort study

Jacqueline Pui Wah Chung, Peter W T Lee, Alex H. Lin, Justin Yuen et al.
BMC Women s Health
Gynecological conditions and treatments
article

Age and persistence of chronic endometritis on repeat biopsy: a 25-year territory-wide cohort study

Jacqueline Pui Wah Chung, Peter W T Lee, Alex H. Lin, Justin Yuen, Joshua J. X. Li, Fenfen Xie, Beili Chen, Tao Zhang, Joanna K. M. Ng
article en

Abstract

Chronic endometritis (CE) is a persistent inflammatory disorder of the endometrium that has been associated with impaired endometrial receptivity and implantation failure. The role of antibiotic therapy has been debated with treatment responses variable. This study aimed to identify factors associated with persistence of CE at follow-up biopsy in a large real-world cohort. Clinical data of patients diagnosed with CE were extracted from the Clinical Data Analysis and Reporting System (CDARS) of the Hong Kong Hospital Authority between January 2000 and December 2024. Patients with histopathologically confirmed CE with follow-up endometrial biopsy were included. Consecutive pathology records within 14 days were collapsed into a single episode; the first and second episodes were designated TP1 and TP2, and only patients with a TP2 episode at least 14 days after TP1 were analyzed. The primary outcome was persistence of CE at TP2. Of 14,988 patients with pathologically confirmed CE, 3,119 had matched follow-up. The overall resolution rate was 79.8% (2,490/3,119). Univariable analysis showed higher odds of persistence with penicillin/beta-lactamase inhibitor (OR 1.41, 95% CI 1.06–1.86, p = 0.016), narrow-spectrum penicillins (OR 1.88, 95% CI 1.09–3.13, p = 0.019) and fluoroquinolones (OR 2.48, 95% CI 1.20–4.92, p = 0.011). After multivariable adjustment, no antibiotic class was significantly associated with treatment outcome. Age was the only factor independently associated with persistence. Compared with the reference group (25–44 years), patients aged 45–59 years had significantly lower odds of persistence (aOR 0.77; 95% CI 0.64–0.93; p = 0.007), whereas those aged ≥ 75 years had higher odds (aOR 2.29; 95% CI, 1.52–3.43; p < 0.001). The ≤ 24-year and 60–74-year groups did not differ significantly from the reference (aOR 0.94, 95% CI 0.14–3.80 and aOR 1.06, 95% CI 0.57–1.86, respectively). Baseline and change in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), or systemic immune-inflammation index (SII) were insignificant (p>0.05). Persistence of CE was associated with age in a non-linear pattern, with lower odds in women aged 45–59 years and higher odds in those aged ≥ 75 years relative to the 25–44-year reference. Antibiotic class is not associated with treatment outcomes, and blood-based inflammatory markers were not associated with treatment response; current data provide insufficient evidence to support their use for routine treatment monitoring. Due to poor model discrimination, age identifies a population at higher risk rather than a usable individual predictor. These findings support further study of age-related persistence but do not support age-based treatment decisions.

BMC Women s Health
Chinese University of Hong Kong (HK), Anhui Medical University (CN), Queen Mary Hospital (CN), First Affiliated Hospital of Anhui Medical University (CN), Queen Elizabeth Hospital (CN), University of Hong Kong (HK)
Good health and well-being
Gynecological conditions and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon